CymaBay Therapeutics
CBAY
$32.48
Share price
0.00%
Change (1 day)
221.27%
Change (1 year)
Categories
EPS for CymaBay Therapeutics (CBAY)
EPS in 2023 (TTM): -$0.88
According to CymaBay Therapeutics 's latest financial reports the company's current EPS (TTM) is -$0.88. In 2022 the company made an earnings per share (EPS) of -$1.21 an increase over its 2021 EPS that were of -$1.27.
EPS history for CymaBay Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.88 | -27.27% |
| 2022 | -$1.21 | -4.72% |
| 2021 | -$1.27 | 69.33% |
| 2020 | -$0.75 | -50.98% |
| 2019 | -$1.53 | 22.4% |
| 2018 | -$1.25 | 56.25% |
| 2017 | -$0.80 | -29.82% |
| 2016 | -$1.14 | 46.15% |
| 2015 | -$0.78 | -71.22% |
| 2014 | -$2.71 | -114.7% |
| 2013 | $18.44 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -311.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -551.14% | 🇺🇸 USA |
 Xencor XNCR | -$2.14 | 143.18% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$8.65 | 882.95% | 🇺🇸 USA |